KILITCH DRUGS (INDIA) LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | UnAudited |
Net Sales | 317.94 | 412.02 | 365.57 | 454.77 |
Total Expenditure | 295.15 | 325.83 | 303.78 | 392.64 |
PBIDT (Excl OI) | 22.79 | 86.19 | 61.79 | 62.13 |
Other Income | 29.56 | 4.89 | 5.62 | 10.2 |
Operating Profit | 52.36 | 91.08 | 67.41 | 72.33 |
Interest | 15.99 | 15.09 | 14.99 | 12.07 |
Exceptional Items | NA | NA | NA | 0.00 |
PBDT | 36.37 | 75.99 | 52.42 | 60.26 |
Depreciation | 8.15 | 8.17 | 7.89 | 9.14 |
Profit Before Tax | 28.22 | 67.82 | 44.53 | 51.12 |
Tax | 10.8 | 16.89 | 13.93 | 22.1 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 17.42 | 50.93 | 30.6 | 29.02 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 17.42 | 50.93 | 30.6 | 29.02 |
Minority Interest | 11.68 | -3.53 | 2.98 | 6.62 |
Shares of Associates | 0 | |||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 29.09 | 47.41 | 33.57 | 35.64 |
Equity Capital | 160.82 | 160.82 | 155.82 | 155.82 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | NA | NA | NA | 1360.15 |
Calculated EPS | 1.80 | 2.94 | 2.15 | 2.28 |
Calculated EPS (Annualised) | 7.23 | 11.79 | 8.61 | 9.14 |
No of Public Share Holdings | 4948146 | 4948146 | 4948146 | 4948146 |
% of Public Share Holdings | 30.77 | 30.77 | 31.75 | 31.75 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 7.16 | 20.91 | 16.90 | 13.66 |
PBIDTM% | 16.46 | 22.10 | 18.43 | 15.90 |
PBDTM% | 11.43 | 18.44 | 14.33 | 13.25 |
PBTM% | 8.87 | 16.46 | 12.18 | 11.24 |
PATM% | 5.47 | 12.36 | 8.37 | 6.38 |
"; | Notes | Notes | Notes | Notes |